Lobe Sciences (CSE: LOBE) (OTCQB: LOBEF) is a “BioPsychedelic” company entering clinical stage development focused on transforming psychedelic medicine to benefit patients of all ages. Lobe Sciences is engaged in research and development using psychedelic and nonpsychedelic compounds targeting the 5HT2 receptor family. The company’s team is made up of biotech executives who collectively have managed the development and regulatory approval of revolutionary drugs around the globe. For more information, visit the company’s website at www.LobeSciencesir.com.

To register for the conference and view the presentation, visit https://planetmicrocapshowcase.com/

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with custom-built portals that include summaries on hundreds of presenting companies. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of various investor conferences.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]